Qunli Ding

516 total citations
39 papers, 387 citations indexed

About

Qunli Ding is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Qunli Ding has authored 39 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Qunli Ding's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Qunli Ding is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Qunli Ding collaborates with scholars based in China. Qunli Ding's co-authors include Shifang Sun, Chao Cao, Zaichun Deng, Yiming Yu, Dan Lv, Ning Xu, Linfeng Wang, Weina Huang, Qiaoli Zhang and Yun Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Qunli Ding

33 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qunli Ding China	12	199	141	121	87	35	39	387
Shifang Sun China	13	127 0.6×	164 1.2×	62 0.5×	108 1.2×	55 1.6×	24	336
Adolfo Baloira Spain	12	343 1.7×	102 0.7×	116 1.0×	59 0.7×	31 0.9×	35	463
Eleni Bibaki Greece	10	261 1.3×	102 0.7×	82 0.7×	37 0.4×	22 0.6×	16	370
Yasuhiro Funada Japan	12	201 1.0×	58 0.4×	139 1.1×	26 0.3×	76 2.2×	35	378
Yingwei Zhang China	9	176 0.9×	113 0.8×	59 0.5×	49 0.6×	22 0.6×	17	369
Veronika Sárosi Hungary	11	180 0.9×	105 0.7×	29 0.2×	38 0.4×	93 2.7×	30	311
Sylvie Honnons France	5	194 1.0×	97 0.7×	26 0.2×	37 0.4×	21 0.6×	6	335
Lingyin Ge United States	9	146 0.7×	116 0.8×	23 0.2×	54 0.6×	15 0.4×	11	329
Tadahisa Numakura Japan	11	113 0.6×	89 0.6×	100 0.8×	18 0.2×	9 0.3×	30	309
Rebecca C. Keith United States	8	434 2.2×	83 0.6×	90 0.7×	25 0.3×	38 1.1×	13	558

Countries citing papers authored by Qunli Ding

Since Specialization

Citations

This map shows the geographic impact of Qunli Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunli Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunli Ding more than expected).

Fields of papers citing papers by Qunli Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunli Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunli Ding. The network helps show where Qunli Ding may publish in the future.

Co-authorship network of co-authors of Qunli Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qunli Ding. A scholar is included among the top collaborators of Qunli Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunli Ding. Qunli Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Wei, et al.. (2025). Interleukin −39 Expression in Pleural Effusion and Its Diagnostic Value for Tuberculous Pleurisy. Journal of Inflammation Research. Volume 18. 4755–4770.

Wu, Tingting, et al.. (2025). Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in interstitial lung disease: a retrospective cohort study. Lara D. Veeken. 64(SI). SI105–SI113. 3 indexed citations

Zhang, Yun, et al.. (2025). Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease. Scientific Reports. 15(1). 21580–21580.

Huang, Minxuan, Mingcai Li, Jie Jin, et al.. (2024). Increased serum IL‑41 associated with acute exacerbation of chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine. 28(2). 312–312.

Zhang, Yun, et al.. (2023). Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities. Annals of Medicine. 55(1). 2204449–2204449. 6 indexed citations

Chen, Wei‐Li, et al.. (2023). The diagnostic value of interleukin-36 cytokines in pleural effusions of varying etiologies. Clinica Chimica Acta. 549. 117533–117533.

Wu, Tingting, et al.. (2022). Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis. Therapeutic Advances in Respiratory Disease. 16. 2673720302–2673720302. 11 indexed citations

Ding, Qunli, et al.. (2022). Efficacy of nintedanib in a patient with acute exacerbation of idiopathic pulmonary fibrosis. British Journal of Hospital Medicine. 83(3). 1–3.

Ding, Qunli, et al.. (2022). Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases. Advances in Rheumatology. 62(1). 37–37. 9 indexed citations

10.

Sun, Shifang, Hailin Chen, Yun Zhang, et al.. (2020). Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN. Life Sciences. 244. 117297–117297. 56 indexed citations

11.

Ding, Qunli, Shifang Sun, Yun Zhang, et al.. (2020). <p>Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome</p>. International Journal of COPD. Volume 15. 357–365. 20 indexed citations

12.

Huang, Jing, et al.. (2018). Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion. Medicine. 97(7). e9996–e9996. 5 indexed citations

13.

Huang, Weina, et al.. (2018). Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. International Journal of COPD. Volume 13. 2695–2705. 61 indexed citations

14.

Huang, Jing, et al.. (2017). Dabigatran-Induced Massive Spontaneous Hemothorax. PubMed. 4(1). 12–12. 5 indexed citations

15.

Ding, Qunli, et al.. (2015). Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review. Experimental and Therapeutic Medicine. 9(3). 829–834. 25 indexed citations

16.

Ding, Qunli, et al.. (2014). A functional EGF+61 polymorphism is associated with severity of obstructive sleep apnea. Sleep And Breathing. 19(2). 495–498. 6 indexed citations

17.

Cao, Chao, et al.. (2013). Evaluation of VEGF-C and Tumor Markers in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis. Scientific Reports. 3(1). 3473–3473. 13 indexed citations

18.

Ding, Qunli, Shifang Sun, Chao Cao, & Zaichun Deng. (2012). Association between Angiotensin-Converting Enzyme I/D Polymorphism and Asthma Risk: A Meta-Analysis Involving 11,897 Subjects. Journal of Asthma. 49(6). 557–562. 14 indexed citations

19.

Cao, Chao, Tao Ying, Shifang Sun, et al.. (2010). Polymorphism of vascular endothelial growth factor –2578C/A with cancer risk: evidence from 11263 subjects. Medical Oncology. 28(4). 1169–1175. 19 indexed citations

20.

Cao, Chao, Tao Ying, Shifang Sun, et al.. (2010). Vascular Endothelial Growth Factor +936C/T and +405G/C Polymorphisms and Cancer Risk: a Meta-analysis. Archives of Medical Research. 41(7). 548–557. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact